Evidence map›Paper›PMID 38794302›Full record

ReviewPharmaceutics2024

Mechanisms of Action of Phytoestrogens and Their Role in Familial Adenomatous Polyposis.

Irene Falsetti, Gaia Palmini, Teresa Iantomasi, Maria Luisa Brandi, Francesco Tonelli

Abstract readReview
In one paragraph

Review in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Irene FalsettiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, 50139 Florence, Italy.
Gaia PalminiFondazione Italiana Ricerca sulle Malattie dell'Osso (FIRMO Onlus), 50129 Florence, Italy.ORCID 0000-0002-8376-7404
Teresa IantomasiDepartment of Experimental and Clinical Biomedical Sciences, University of Florence, 50139 Florence, Italy.ORCID 0000-0001-7461-330X
Maria Luisa BrandiFondazione Italiana Ricerca sulle Malattie dell'Osso (FIRMO Onlus), 50129 Florence, Italy.ORCID 0000-0002-8741-0592
Francesco TonelliFondazione Italiana Ricerca sulle Malattie dell'Osso (FIRMO Onlus), 50129 Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Familial adenomatous polyposis (FAP) is a rare disease characterized by the development of adenomatous polyps in the colon and rectum already in adolescence. If left untreated, patients develop colorectal cancer (CRC) with a 100% probability. To date, the gold standard of FAP management is surgery, which is associated with morbidity and mortality. A chemopreventive agent capable of delaying, preventing and reversing the development of CRC has been sought. Several classes of drugs have been used but to date no chemopreventive drug has been found for the management of this disease. In recent years, the importance of estrogen receptors in FAP and CRC, particularly the β subtype, has emerged. Indeed, the expression of the latter is strongly reduced in adenomatous polyps and CRC and is inversely correlated with the aggressiveness of the disease. Since phytoestrogens have a high affinity for this receptor, they have been suggested for use as chemopreventive agents in FAP and CRC. A combination of phytoestrogens and insoluble fibres has proved particularly effective. In this review, the various mechanisms of action of phytoestrogens were analyzed and the effectiveness of using phytoestrogens as an effective chemopreventive strategy was discussed.

Indexed as

colorectal cancerestrogen receptor βfamilial adenomatous polyposisphytoestrogens

Identifiers

PMID38794302
PMCPMC11125335

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.